Effect of Triterpenoids Isolated from the Floral Spikes of Betula platyphylla var. japonica on P-Glycoprotein Function

Abstract

One of the major causes of multidrug resistance (MDR) in cancer cells is over-expression of P-glycoprotein (P-gp). We studied the effects of 20 triterpenes isolated from the floral spikes of Betula platyphylla var. japonica (B. platyphylla) on P-gp function based on our previous finding that some of them showed MDR reversing effects. We evaluated accumulations and effluxes of rhodamine 123 as a P-gp substrate with P-gp over-expressing KB-C2 cells. Among the 20 triterpenes, compounds 3, 4, 8, 9, 13, 15, and 20 increased rhodamine 123 accumulations in KB-C2 cells, and three (8, 13, and 20) of them also inhibited efflux of rhodamine 123 out of cells. In addition, compounds 13 and 20 showed a weak inhibitory activity of P-gp ATPase. These results suggested that MDR reversing effects of compounds 13 and 20 are partly involved in inhibition of P-gp ATPase.

Abbreviations

B. platyphylla:Betula platyphylla var. japonica

DMEM:Dulbecco’s modified Eagle’s medium

EDTA:ethylendiamine-N,N,N′,N′-tetraacetic acid

EGTA:O,O′-bis(2-aminoethyl)ethyleneglycol-N,N,N′,N′-tetraacetic acid

FBS:fetal bovine serum

HEPES:2-[4-(2-hydroxyethyl)-1-piperazinyl]ethane-sulfonic acid

MDR:multidrug resistance

PBS:phosphate-buffered saline

P-gp:P-glycoprotein

Tris:2-amino-2-hydroxymethyl-1,3-propanediol

Betula platyphylla var. japonica - Betulaceae - triterpenes - P-glycoprotein - KB-C2 cells

References

• 1 Borowski S, Bontemps-Gracz M M, Piwkowska A. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.  Acta Biochim Pol. 2005;  52 609-27.
• 2 Kashiwada Y, Sekiya M, Yamazaki K, Ikeshiro Y, Fujioka T, Yamagishi T. et al . Triterpenoids from the spikes of Betula platyphylla var. japonica, and their reversing activity against multidrug resistant cancer cells.  J Nat Prod. 2007;  70 623-7.
• 3 Castro A F, Altenberg G A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.  Biochem Pharmacol. 1997;  53 89-93.
• 4 Sumizawa T, Chen Z S, Chuman Y, Seto K, Furukawa T, Haraguchi M. et al . Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.  Mol Pharmacol. 1997;  51 399-405.
• 5 Litman T, Zeuthen T, Skovsgaard T, Stein W D. ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines.  Biochim Biophys Acta. 1997;  1361 159-68.
• 6 Chifflet S, Torriglia A, Chiesa R, Tolosa S. A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: Application to lens ATPases.  Anal Biochem. 1988;  168 1-4.
• 7 Borgnia M J, Eytan G D, Assaraf Y G. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed its ATPase activity.  J Biol Chem. 1996;  271 3163-71.
• 8 Kitagawa S, Nabekura T, Kamiyama S. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells.  J Pharm Pharmacol. 2004;  56 1001-5.
• 9 Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols.  J Pharm Pharmacol. 2004;  56 1307-14.
• 10 Weerasinghe P, Hallock S, Tang S C, Trump B, Liepins A. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.  Exp Toxicol Pathol. 2006;  58 21-30.
• 11 Ramachandran C, Rabi T, Fonseca H B, Melnick S J, Escalon E A. Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines.  Int J Cancer. 2003;  105 784-9.
• 12 Weber C C, Reising K, Müller W E, Schubert-Zsilavecz M, Abdel-Tawab M. Modulation of Pgp function by boswellic acids.  Planta Med. 2006;  72 507-13.
• 13 Kim S W, Kwon H Y, Chi D W, Shim J H, Park J D, Lee Y H. et al . Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3.  Biochem Pharmacol. 2003;  65 75-82.
• 14 Watanabe T, Kokubu N, Charnick S B, Naito M, Tsuruo T, Cohen D. Interaction of cyclosporine derivatives with the ATPase activity of human P-glycoprotein.  Br J Pharmacol. 1997;  122 241-8.
• 15 Litman T, Druley T E, Stein W D, Bates S E. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.  Cell Mol Life Sci. 2001;  58 931-59.